Leadership Rotation For Fight The Fakes Campaign 09/02/2017 by Intellectual Property Watch 1 Comment A new industry group today took the reins of the Fight the Fakes campaign, a growing coalition against fake medicines, the first rotation in leadership since its launch in late 2013.
Patentability Of Some Biotech Uncertain In Europe As Examination, Opposition Suspended 09/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The patentability of plants or animals that have been obtained by natural occurrence such as selection and crossing has been a recurrent issue discussed at the European Patent Office (EPO). A recent notice from the European Commission challenged a ruling by the EPO Enlarged Board of Appeal on such patents, prompting yet more discussions in the organisation. In the meantime, all examination and opposition on such patents have been halted at the EPO. Industry is concerned that the EPO ruling might be questioned, and warns of effects on innovation, harm to applicants. Civil society is concerned about a non-transparent process.
US Chamber International IP Index: US, Europe At Top; India Needs A Push 08/02/2017 by William New, Intellectual Property Watch 2 Comments The United States Chamber of Commerce today released its fifth annual International IP Index, which makes the case for the positive impact of intellectual property on economies. The United States scored highest, followed by top European economies and Japan. And near the bottom was India, despite recent efforts to accept the IP system. Separately, the report assesses international trade rules for IP and argues for nations to negotiate “TRIPS-plus” agreements.
Government-Financed R&D Declining; Private Sector, Tax Incentives Rise, OECD Finds 07/02/2017 by Intellectual Property Watch 1 Comment A new set of science and technology indicators shows that the business sector is expected to remain the driving force behind research and development growth, according to the Organisation for Economic Co-operation and Development (OECD). The OECD released its main science and technology indicators today and found that government-financed research and development expenditures have been declining for some years.
Confidential Draft Of WHO Cancer Resolution Shows Remaining Issues IP-Related 07/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The latest version of a draft resolution on addressing the global rise of cancer negotiated last week at the World Health Organization shows that remaining points are intellectual property-related, but there seems to be agreement on referencing trade flexibilities in the text, even from the United States, and a common goal of lowering prices of treatment. WHO members tried to reach common language during the Executive Board in January but time ran out and discussions are expected to continue until the annual World Health Assembly in May.
The New Caribbean Patent Convention And Caricom Stasis 06/02/2017 by Intellectual Property Watch 3 Comments Abiola Inniss writes: The creation of the Caribbean Patent Convention under the auspices of Caricom is a long awaited and most welcome development towards the harmonization of intellectual property laws in the region. Even more importantly, it is an indication that Caricom leadership has at long last, after a lengthy period of stagnation and indeterminacy, finally decided to engage the process of thought and action necessary for the promulgation of a legal and regulatory framework for Caribbean intellectual property. The convention is expected to be enacted later in 2017.
Report Puts Value Of Counterfeit/Pirated Goods At US$2 Trillion By 2022 06/02/2017 by Intellectual Property Watch 2 Comments A new report by the International Chamber of Commerce (ICC) and the International Trademark Association (INTA) estimates that some US$213 billion was lost to digital piracy in movies, music and software in 2015. The report also projects that by 2022, the total value of counterfeit and pirated goods in the world will reach somewhere between US$1.9 to 2.8 trillion.
Pharma Joins Atomic Energy Agency On Cancer Treatment Training In Poor Countries 06/02/2017 by Intellectual Property Watch 1 Comment Seeking to address the growing issue of cancer, and in particular the lack of access to diagnosis and treatment in low and middle-income countries, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Atomic Energy Agency (IAEA) have entered into a collaboration.
WIPO Report Recommends More “Cooperation” Under Patent Cooperation Treaty 03/02/2017 by Intellectual Property Watch 3 Comments As it published the three-millionth international patent application under its Patent Cooperation Treaty (PCT) on 2 February, the World Intellectual Property Office suggested that there may be ways to improve the system in the future.
No Shorter Floor Statements Nor Cap On Agenda Items, Says WHO Board 03/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Despite being in a time of tight budgets, the World Health Organization Executive Board meeting which ended this week had its heaviest agenda ever, according WHO Director General Margaret Chan, adding to staff workload and expenses. But the Board finished its work a day early (though after holding three evening sessions), earning praise from Chan. Efforts during the week to make meetings more efficient by limiting agenda items and reducing time allowed for statements fell short. Separately, concerns arose over a leadership advisory group to the WHO director general.